Our Board

The ALLG is an Australian not-for-profit, public unlisted company limited by guarantee and is a registered charity.

ALLG Board of Management

The ALLG is governed on behalf of members by a Board of Management in accordance with the ALLG constitution. Subject to the exercise by the Board of the powers contained in the constitution, the Board manages the company and directs the affairs of the company. Current Board members are:

Chairman of the Board
Mr Peter Kempen
FCA, FAICD

Peter was appointed to the Board as a Director and Chairman in early 2010. He is a member of the Finance and Audit Committee of the Board.

- View Profile

Peter was a senior partner of Ernst and Young up to 2003 and Managing Partner of the Australian firm's Corporate Finance practice. Since leaving professional practice Peter has been a professional non executive company director serving on the Board of three publicly listed companies (all as Chairman) as well as a number of private companies and not for profit organisations.

Peter is Chairman of Pro Medicus Ltd (a medical IT company), Chairman of Ivanhoe Grammar School and a Director of Yara Pilbara Holdings and its subsidiaries and associated companies. He serves as a Council member of St Hilda's College, University of Melbourne and is a Director and Trustee of the Barr Family Foundation (a philanthropic trust).

Peter is a former Chairman of Patties Foods Ltd and former Chairman of Danks Holdings Ltd. Peter is also a former Chairman of Independent Schools Victoria. Peter has also served as Chairman of the State Council of Victoria and as a National Councillor of the Institute of Chartered Accountants in Australia.

Chairman of the Scientific Advisory Committee (SAC)
Professor Mark Hertzberg
MBBS, PhD, FRACP, FRCPA
Prince of Wales Hospital, Sydney

Mark first joined the ALLG Executive in 2007 and has been an active member of the organisation serving not only as Chair of the Aggressive DLBCL Disease Group Committee for more than 7 years, but also for 2 years as Treasurer as well as a member of the SAC and the Board since 2010.

- View Profile

Mark Hertzberg is a Clinical Professor of Haematology at Prince of Wales Hospital, and the University of Sydney. His clinical and research interests include Lymphoma, Reduced-intensity Allogeneic Stem Cell Transplantation, and the Molecular Monitoring of Leukaemia. He is current Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group and a Past President of the Haematology Society of Australia & New Zealand.

Associate Professor Peter Bardy
MBBS, FRACP, FRCPA
Queen Elizabeth Hospital, Adelaide

Peter has been an active member of the Company since May 2005. He brings a breadth of experience linked to his ongoing active involvement in patient care to the Company board.

- View Profile

A/Prof Peter Bardy has been an active member of the Company since May 2005. He was the inaugural chair of the Supportive Care group and was actively involved in the external review of the Company which commended the establishment of the Company board. He subsequently chaired the selection panel that saw the appointment of the external Board members. In recent years he has taken on a number of senior health administration roles (Director of the Division of Medicine the Queen Elizabeth Hospital, Chair of the SA clinical Senate, CMO for the Central and Northern Health Service, and currently Clinical Director for the newly formed Central Adelaide LHN Cancer service). He brings this breadth of experience linked to his ongoing active involvement in patient care to the Company board.

Ms Prue Deniz
GradDipIntBus, BBus(Marketing)/BArts(Korean)

Prue was elected to the board as a Director in May 2014 and performs the role of the Chairperson of the Marketing Committee of the Board. Prue has extensive experience in all key internal and external drivers necessary to grow a company's brand and reputation and is looking forward to applying this experience to increase the public profile of ALLG.

- View Profile

Prue spent the early years of her career working for global Public Relations agencies in Melbourne, London and Dublin. During this period, Prue supported a range of clients within the FMCG, IT, Technology and Telecommunications industries.

In 2002 Prue joined Telstra's advertising subsidiary in Melbourne as public relations manager before assuming the role of Executive General Manager Corporate Affairs and Sustainability in 2006. In this role Prue was a member of Sensis' Executive Board responsible for setting and delivering the strategic priorities and governance framework of the company while also managing a portfolio comprising government relations, investor relations, corporate reputation, external communications internal communications, and sustainability.

In 2012 Prue joined Amcor, a global packaging company with annual sales of $10b operating in 43 countries. Servicing the food, beverage and healthcare industries, as Vice President Corporate Communications, Prue is responsible for devising strategies to build and protect Amcor's reputation with its key stakeholder groups from employees to customers, community, industry, and media.

Prue holds a double degree in Business/Arts (Marketing/Korean) and a graduate diploma in International Business.

Ms Geraldine Gray
BA, LLB, LLM

Geraldine was appointed to the Board as a Director in early 2010. She is a member of the Marketing Committee of the Board.

- View Profile

Geraldine is a barrister practising at the Victorian bar with a particular experience of and interest in health law. Her legal experience covers more than 20 years in Melbourne, Sydney and Hong Kong. Geraldine has supplemented her medico-legal exprience with role as legal representative, Mercy Health & Aged Care Human Research Ethics Committee and as Editor of the Journal of the Formosan Medical Association (published by National Taiwan University).

Geraldine is a member of the Society of Construction Law, the Building Dispute Practitioners' Society, the National Association of Women in Construction and the Australian Insurance Law Association.

Mr Malcolm McComas
BEc, LLB, SF Fin, FAICD

Malcolm was elected to the Board, and has performed the role of Chairman of the Finance and Audit Committee of the Board, since May 2010. He has over 25 years experience in investment banking with leadership roles at several global financial institutions.

- View Profile

Malcolm is a Sydney based company director with a background in investment banking, finance and law. He has over 25 years experience in investment banking with leadership roles at several global financial institutions. Over the last 10 years, Malcolm has focused on various board roles with public and private companies and not-for-profit entities. He became a director of ALLG in May 2010 and is currently a director or chairman of several other entities in the resources, healthcare, finance and industrial sectors.

Ms Tina Rankovic
Dip Diag Rad, GradDip Man, MBus

Tina was elected to the Board as a Director in early 2013 with aims to embed fund-raising as a core operational activity utilising her skills, experience and networks. She is a member of the Marketing Committee of the Board.

- View Profile

Tina Rankovic is an experienced CEO and leader with a strong business management and technical background gained through senior management roles in multi-national corporations, public sector organisations and start-up businesses in the healthcare, life sciences, engineering, biotechnology, 'cleantech' and tertiary education and research sectors. Her expertise gained in Australia and internationally, includes sales management, marketing and communications management, business development, product management, contract management, strategic planning, human resource and stakeholder management, finance, project management, infrastructure management including IT, research translation and technology commercialisation, risk management, R&D management and operations.

Most recently, Tina has been the Associate Pro Vice Chancellor Knowledge Exchange at Victoria University. For the past ten years, her career has been concentrated on the translation of research outcomes into commercial products and services; she is passionate about seeing Australian innovation commercialised in domestic and global markets.

Tina has a Diploma of Diagnostic Radiography and her post-graduate qualifications include a Graduate Diploma of Management (Royal Melbourne Institute of Technology) and a Masters of Business degree majoring in innovation and marketing management (Swinburne University of Technology). Additionally, Tina is a member of the Australian Institute of Company Directors (AICD) and has completed the AICD Company Directors course.

Professor Andrew Roberts
MBBS, PhD, FRACP, FRCPA
Royal Melbourne Hospital, Melbourne

- View Profile

 

Professor Philip Rowlings
MBBS, FRACP, FRCPA, MS
Calvary Mater Newcastle Hospital, Sydney

Phil was elected to the Board as a Director in October 2016. He has over 30 years research experience in clinical trials of new treatments, biostatistical analyses of large datasets in blood and marrow transplant for leukaemia, multiple myeloma, lymphoma and other malignancies.

- View Profile

Professor Philip Rowlings has over 30 years research experience in clinical trials in Haematology. He has vast experience in biostatistical analyses of large datasets in blood and marrow transplant for leukaemia, multiple myeloma, lymphoma and other malignancies, as well as health resource utilisation. In the last 15 years he has also been involved in novel work in autologous bone marrow stem cell therapy for heart disease and genetic analyses in multiple myeloma, amongst other projects. He has been Director of Haematology for Calvary Mater Newcastle and Hunter New England Health District since 2010. His department has a large clinical trials department which usually contributes 5-10% of Australian totals of ALLG and other national trials, as well as piloting novel ALLG trials in AML.

Philip is a member of Scientific Advisory Committee of the Asia Pacific Bone Marrow Transplant (APBMT) group based in Ngoya, Japan. He is an executive member of NSW BMT advisory committee, a board member of the World Wide Blood and Marrow Transplant Network (WBMT), and served as a Scientific Director of the Center for International Blood and Marrow Transplant Research (CIBMTR, based in Milwaukee and Minneapolis, USA) from 1992-1998.

Philip has been an ALLG member since the mid-1980s participating in the early ALSG AML clinical trials. Following his return from the USA in 1998 he participated in the unification of the ALSG and ANZLG to become ALLG. He developed the initial operating procedures, and was the founding Chair of the ALLG Data Safety Monitoring Committee.